Style | Citing Format |
---|---|
MLA | Afsharzadeh M, et al.. "Targeted Delivery of Liposomal Ribociclib to Slc7a5 Transporters in Breast Cancer Cells." Investigational New Drugs, vol. 42, no. 1, 2024, pp. 89-105. |
APA | Afsharzadeh M, Varshosaz J, Mirian M, Hasanzadeh F (2024). Targeted Delivery of Liposomal Ribociclib to Slc7a5 Transporters in Breast Cancer Cells. Investigational New Drugs, 42(1), 89-105. |
Chicago | Afsharzadeh M, Varshosaz J, Mirian M, Hasanzadeh F. "Targeted Delivery of Liposomal Ribociclib to Slc7a5 Transporters in Breast Cancer Cells." Investigational New Drugs 42, no. 1 (2024): 89-105. |
Harvard | Afsharzadeh M et al. (2024) 'Targeted Delivery of Liposomal Ribociclib to Slc7a5 Transporters in Breast Cancer Cells', Investigational New Drugs, 42(1), pp. 89-105. |
Vancouver | Afsharzadeh M, Varshosaz J, Mirian M, Hasanzadeh F. Targeted Delivery of Liposomal Ribociclib to Slc7a5 Transporters in Breast Cancer Cells. Investigational New Drugs. 2024;42(1):89-105. |
BibTex | @article{ author = {Afsharzadeh M and Varshosaz J and Mirian M and Hasanzadeh F}, title = {Targeted Delivery of Liposomal Ribociclib to Slc7a5 Transporters in Breast Cancer Cells}, journal = {Investigational New Drugs}, volume = {42}, number = {1}, pages = {89-105}, year = {2024} } |
RIS | TY - JOUR AU - Afsharzadeh M AU - Varshosaz J AU - Mirian M AU - Hasanzadeh F TI - Targeted Delivery of Liposomal Ribociclib to Slc7a5 Transporters in Breast Cancer Cells JO - Investigational New Drugs VL - 42 IS - 1 SP - 89 EP - 105 PY - 2024 ER - |